Standard Biotools (LAB) EPS (Basic) Growth (5y) (2015 - 2026)
Standard Biotools (LAB) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Standard Biotools | 253.06 Mn | -223.66 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.05% |
| Mar 31, 2026 | 28.11% |
| Dec 31, 2025 | 53.11% |
| Sep 30, 2025 | -1.69% |
| Jun 30, 2025 | 24.03% |
| Mar 31, 2025 | 50.05% |
| Dec 31, 2024 | 17.15% |
| Sep 30, 2024 | 20.48% |
| Jun 30, 2024 | 19.24% |
| Mar 31, 2024 | 24.18% |
| Dec 31, 2023 | 19.91% |
| Sep 30, 2023 | 6.67% |
| Jun 30, 2023 | 12.25% |
| Mar 31, 2023 | 8.96% |
| Dec 31, 2022 | 52.21% |
| Sep 30, 2022 | 4.23% |
| Jun 30, 2022 | -7.19% |
| Mar 31, 2022 | -10.98% |
| Sep 30, 2021 | 0.84% |
| Jun 30, 2021 | 5.82% |